Skip to main content

Select Drug Profiles

Cost-Effective Imaging: What Parameters Determine Value?
Mary Mosley
Read More
Novel Oral Anticoagulants Reduce Total Medical Costs in Patients with Nonvalvular Atrial Fibrillation
Mary Mosley
Read More
AVERROES: Cost Comparison of Apixaban versus Aspirin
Read More
Conference Highlights AMCP
Electronic Service Alerts Providers of Low-Cost Drugs, Shows Significant Cost-Savings
Read More
Conference Highlights AMCP
Consumer-Directed Health Plans’ Impact on Medication Adherence in Chronic Conditions
Read More
Conference Highlights AMCP
High-Deductible Health Plans: Mixed Results in Clinical Outcomes, Associated Costs
Read More
Conference Highlights AMCP
Pharmacists’ Knowledge Gap about Oncology Genetic Testing, Benefit Design
Read More
Conference Highlights AMCP
Comparing Cost-Effectiveness of First-Line Therapies for Advanced NSCLC
Read More
Practice Management
Recent Developments, Utilization, and Spending Trends for Pompe Disease Therapies
Jing Guo, BPharm, Christina M.L. Kelton, PhD, Jeff J. Guo, PhD
Stakeholder Perspective
Beyond “Patient Amusement”: New Treatments and Genetic Disease
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Practice Management
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Delete Delete, Jonah Broulette, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Winghan Jacqueline Kwong, PharmD, PhD, Michael F. Murphy, MD, PhD
Stakeholder Perspective
Warfarin Utilization in Medicare Patients with Nonvalvular Atrial Fibrillation: Sentinel Data from an Administrative Claims Database
Read More
Page 205 of 244
Results 2041 - 2050 of 2438